Zagni, Emanuela
Frassi, Micol
Mariano, Giuseppa Pagano
Fusaro, Enrico
Lomater, Claudia
Del Medico, Patrizia
Iannone, Florenzo
Foti, Rosario
Limonta, Massimiliano
Marchesoni, Antonio
Raffeiner, Bernd
Viapiana, Ombretta
Grassi, Walter
Grembiale, Rosa Daniela
Guggino, Giuliana
Mazzone, Antonino
Tirri, Enrico
Perricone, Roberto
Sarzi Puttini, Pier Carlo
De Vita, Salvatore
Conti, Fabrizio
Zullo, Alessandro
Simoni, Lucia
Fiocchi, Martina
Orsenigo, Roberto
Colombo, Delia
Article History
Received: 15 June 2021
Accepted: 12 December 2022
First Online: 16 December 2022
Declarations
:
: The study was conducted in accordance with the amended Declaration of Helsinki. Ethical approval for this study was obtained from each participating site according to Italian Regulation applicable for prospective observational studies.The patients provided written informed consent to their involvement in the study.The study was approved by the Ethic Committee of the coordinating center (A.O.U. Policlinico-Vittorio Emanuele P.O. San Marco, Catania, Italy).
: Not applicable.
: Dr. Zagni is an employee of Novartis Farma Italy.Dr. Marchesoni reports grants from Novartis, during the conduct of the study; personal fees from Novartis, Abbvie, Pfizer, Eli Lilly, UCB, Janssen, outside the submitted work.Dr. Zullo is employee of MediNeos Observational Research (Modena, Italy), hired by Novartis Farma Italy, responsible for the design and conduction of the CHRONOS study, as well as scientific support, clinical operations, data management, statistical analysis.Dr. Simoni is employee of MediNeos Observational Research (Modena, Italy), hired by Novartis Farma Italy, responsible for the design and conduction of the CHRONOS study, as well as scientific support, clinical operations, data management, statistical analysis.Dr. Fiocchi is an employee of Novartis Farma Italy.Dr. Orsenigo is an employee of Novartis Farma Italy.Dr. Colombo is a part-time employee of Novartis Farma Italy.No further CoI were declared for all other authors.